-
Entity
-
Company
-
Location
-
200 Barr Harbor Drive, Suite 400, West Conshohocken, PA
-
Summary
-
The estimated value of insider holdings of Fairmount Funds Management LLC is at least $347M dollars as of October 1, 2024. Fairmount Funds Management LLC is the Director of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $80.1M. Fairmount Funds Management LLC is the Director, 10%+ Owner of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $77.6M. Fairmount Funds Management LLC is the Director, 10%+ Owner of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $64.6M. Fairmount Funds Management LLC is the Director of Cogent Biosciences, Inc. and owns shares of Cogent Biosciences, Inc. (COGT) stock worth about $46.7M. Fairmount Funds Management LLC is the Director of Dianthus Therapeutics, Inc. /DE/ and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $42.4M. Fairmount Funds Management LLC is the Director of Zenas BioPharma, Inc. and owns shares of Zenas BioPharma, Inc. (ZBIO) stock worth about $32.2M. Fairmount Funds Management LLC is the Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $3.43M.